Unknown

Dataset Information

0

A Longitudinal Study of Total and Phosphorylated ?-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.


ABSTRACT: Alzheimer's disease (AD) features a dynamic sequence of amyloid deposition, neurodegeneration, and cognitive impairment. A significant fraction of AD brains also displays Lewy body pathology, suggesting that addition of classically Parkinson's disease-related proteins to the AD biomarker panel may be of value. To determine whether addition of cerebrospinal fluid (CSF) total ?-synuclein and its form phosphorylated at S129 (pS129) to the AD biomarker panel [Amyloid-?1-42 (A?42), tau, and phosphorylated tau (p-tau181)] improves its performance, we examined CSF samples collected longitudinally up to 7 years as part of the Alzheimer's Disease Neuroimaging Initiative. From 87 AD, 177 mild cognitive impairment (MCI), and 104 age-matched healthy controls, 792 baseline and longitudinal CSF samples were tested for total ?-synuclein, pS129, A?42, tau, and p-tau181. pS129, but not total ?-synuclein, was weakly associated with diagnosis at baseline when t-tau/A?42 was included in the statistical model (?=?0.0026, p?=?0.041, 95% CI [(0.0001)-(0.005)]). CSF ?-synuclein predicted Alzheimer's Disease Assessment Scale-Cognitive (?=?-0.59, p?=?0.0015, 95% CI [(-0.96)-(-0.23)]), memory (?=?0.4, p?=?0.00025, 95% CI [(0.16)-(0.59)]), and executive (0.62,<0.0001, 95% CI [(0.31)-(0.93)]) function composite scores, and progression from MCI to AD (?=?0.019, p?=?0.0011, 95% CI [(0.002)-(0.20)]). pS129 was associated with executive function (?=?-2.55, p?=?0.0085, 95% CI [(-4.45)-(-0.66)]). Lower values in the mismatch between ?-synuclein and p-tau181 predicted faster cognitive decline (?=?0.64, p?=?0.0012, 95% CI [(0.48)-(0.84)]). Longitudinal biomarker changes did not differ between groups, and may not reflect AD progression. The ?-synuclein-p-tau181-Mismatch could better predict longitudinal cognitive changes than classical AD markers alone, and its pathological correlates should be investigated further.

SUBMITTER: Wang H 

PROVIDER: S-EPMC5828159 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.

Wang Hua H   Stewart Tessandra T   Toledo Jon B JB   Ginghina Carmen C   Tang Lu L   Atik Anzari A   Aro Patrick P   Shaw Leslie M LM   Trojanowski John Q JQ   Galasko Douglas R DR   Edland Steven S   Jensen Poul H PH   Shi Min M   Zhang Jing J  

Journal of Alzheimer's disease : JAD 20180101 4


Alzheimer's disease (AD) features a dynamic sequence of amyloid deposition, neurodegeneration, and cognitive impairment. A significant fraction of AD brains also displays Lewy body pathology, suggesting that addition of classically Parkinson's disease-related proteins to the AD biomarker panel may be of value. To determine whether addition of cerebrospinal fluid (CSF) total α-synuclein and its form phosphorylated at S129 (pS129) to the AD biomarker panel [Amyloid-β1-42 (Aβ42), tau, and phosphory  ...[more]

Similar Datasets

| S-EPMC3740054 | biostudies-literature
| S-EPMC3175115 | biostudies-literature
| S-EPMC4640280 | biostudies-other
| S-EPMC5562658 | biostudies-other
2024-02-26 | GSE215789 | GEO